PHPSX
Price
$16.90
Change
+$0.47 (+2.86%)
Updated
Apr 17 closing price
Net Assets
2.16M
RYVYX
Price
$394.48
Change
-$0.29 (-0.07%)
Updated
Apr 17 closing price
Net Assets
579.64M
Ad is loading...

PHPSX vs RYVYX

Header iconPHPSX vs RYVYX Comparison
Open Charts PHPSX vs RYVYXBanner chart's image
ProFunds Pharmaceuticals UltraSector Svc
Price$16.90
Change+$0.47 (+2.86%)
VolumeN/A
Net Assets2.16M
Rydex NASDAQ-100® 2x Strategy H
Price$394.48
Change-$0.29 (-0.07%)
VolumeN/A
Net Assets579.64M
PHPSX vs RYVYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PHPSX vs. RYVYX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHPSX is a Hold and RYVYX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 580M vs. PHPSX (2.16M). PHPSX (0.00) and RYVYX (0.00) have matching dividends . PHPSX was incepted earlier than RYVYX: PHPSX (25 years) vs RYVYX (25 years). PHPSX (3.50) is less costly to investors than RYVYX (2.00). RYVYX is a more actively managed with annual turnover of: 392.00 vs. PHPSX (207.00). RYVYX has a lower initial minimum investment than PHPSX: RYVYX (2500) vs PHPSX (15000). RYVYX annual gain was more profitable for investors over the last year : -8.31 vs. PHPSX (-12.09). RYVYX return over 5 years is better than : 120.78 vs. PHPSX (-11.04).
PHPSXRYVYXPHPSX / RYVYX
Total Expense Ratio2.781.89147%
Annual Report Gross Expense Ratio3.502.00175%
Fund Existence25 years25 years-
Gain YTD-19.815-28.27370%
Front LoadN/AN/A-
Min. Initial Investment150002500600%
Min. Initial Investment IRAN/AN/A-
Net Assets2.16M580M0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-12.09-8.31146%
Returns for 3 years-34.0416.75-203%
Returns for 5 years-11.04120.78-9%
Returns for 10 years-28.25415.12-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCSRX8.19N/A
N/A
Fidelity Advisor Strategic Real Ret C
RRGTX6.90N/A
N/A
DWS RREEF Global Real Estate Secc S
PHLCX11.33N/A
N/A
PGIM Jennison Health Sciences C
PRJZX39.33N/A
N/A
PGIM Jennison Global Opportunities Z
JHFEX11.68N/A
N/A
JHancock Fundamental Equity Inc I